共 50 条
Management of Overt Hepatic Encephalopathy
被引:22
|作者:
Khungar, Vandana
[1
,2
]
Poordad, Fred
[1
,3
]
机构:
[1] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[3] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA
关键词:
Hepatic encephalopathy;
Liver disease;
Cirrhosis;
Overt hepatic encephalopathy;
INTRAHEPATIC PORTOSYSTEMIC SHUNT;
ORNITHINE-L-ASPARTATE;
PORTAL-SYSTEMIC ENCEPHALOPATHY;
RANDOMIZED CONTROLLED-TRIAL;
ORAL ZINC SUPPLEMENTATION;
DOUBLE-BLIND;
RIFAXIMIN TREATMENT;
LIVER-CIRRHOSIS;
CLINICAL-TRIAL;
AMMONIA LEVELS;
D O I:
10.1016/j.cld.2011.12.007
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Hepatic encephalopathy (HE) is a potentially reversible state of impaired cognitive function or altered consciousness in patients with liver disease or portosystemic shunting. Overt HE is a particularly pressing problem. Given the many targets of treatment and lack of a clear singular cause of overt HE, there is no consensus on a single best treatment. Over the past several years, high-quality studies have been conducted on the various pharmacologic therapies for HE and, as more data emerge, hopefully HE will become a much more easily treated complication of decompensated liver disease.
引用
收藏
页码:73 / +
页数:18
相关论文